期刊文献+

GC测定盐酸帕洛诺司琼原料药中(S)-3-氨基-奎宁的含量

Determination of(S )-3-Aminoquinuclidine Content in Drug Substance of Palonosetron Hydrochloride by GC
下载PDF
导出
摘要 目的:建立气相色谱法测定盐酸帕洛诺司琼原料药中(S)-3-氨基-奎宁含量的方法。方法:采用SE-30色谱柱(53 mm×60 m,5μm),起始温度100℃,维持5 min,再以20℃/min的速度升温至180℃,维持15 min,FID检测器。结果:(S)-3-氨基-奎宁线环性关系良好,相关系数为0.999 7,定量限为0.007 5 mg/m L,检测限为0.002 5 mg/m L,方法回收率为101.4%,RSD为3.2%,满足要求。结论:本法灵敏、可靠,可用于盐酸帕洛诺司琼原料药中(S)-3-氨基-奎宁的质量控制。 Objective :To develop an GC method for determination of(S)-3-aminoquinuclidine content in drug substance of palonosetron hydrochloride. Methods : A SE-30 column(53 mm × 60 m, 5 μm) was used at an initial temperature of 100 ℃ for 5 min, then the temperature increased at a rate of 20 ℃ / min to 180 ℃ and was maintained for 15 min. The detector used was FID. Results : The calibration curve of(S)-3-aminoquinuclidine showed good linearity, with a correlation coefficient of 0.999 7. The limit of quantitatiion(LOQ) and limit of detection(LOD) of the method were 0.007 5 and 0.002 5 mg/m L respectively, while the recovery rate was 101. 4%,with a RSD of 3.2%, which met the relevant requirements. Conclusion :The developed method was sensitive and reliable, which was applicable for the quality control of(S)-3-aminoquinuclidine in drug substance of palonosetron hydrochloride.
作者 曹天海
出处 《中国执业药师》 CAS 2016年第3期27-29,共3页 China Licensed Pharmacist
关键词 盐酸帕洛诺司琼 气相色谱 (S)-3-氨基-奎宁 含量 Palonosetron Hydrochloride GC (S)-3-Aminoquinuclidine Content
  • 相关文献

参考文献2

  • 1杨新华,欧阳强.盐酸帕洛诺司琼合成路线图解[J].中国医药工业杂志,2009,40(3):231-233. 被引量:4
  • 2Demian I, Gripshover DF. Enantiomeric purity determination of 3-aminoquinuclidine by diastereomeric derivatization and high- performance liquid chromatographic separation[J]. J Chromatog- raphy, 1989, (466) :415-420.

二级参考文献11

  • 1林清强,叶锦林.新型5-HT3受体拮抗剂帕洛诺司琼[J].中国科技信息,2005(11):157-157. 被引量:12
  • 2王海凤,王东凯.5-HT_3受体阻滞剂帕洛诺司琼[J].中国新药杂志,2006,15(10):833-835. 被引量:16
  • 3Alois DC, Andrew KB. Process for the preparation of 2- (1 -azabicyclo (2.2.2) oct-3-yl) -2,4,5,6-tetrahydro- IH- benz (de) isoquinolin-l-one and intermediate product: WO, 9601824 [P]. 1996-01-25. (CA 1996, 124: 289284)
  • 4Berger J, Clark RD, Eglen RM, et al. New tricyclic compounds: EP, 430190 [P]. 1991-01-05. (CA 1991, 115: 114377)
  • 5Tamura R, Sato M, Oda D. Facile synthesis of allylic nitro compounds by N,N-dimethylethylenediamine-catalyzed condensation of aliphatic and alicyclic ketones with primary nitroalkanes [J].J Org Chem, 1986, 51 (23) : 4368-4375.
  • 6Langlois M, Meyer C, Soulier JL, et al. Synthesis of (R) and (S) -3-aminoquinuclidine from 3-quinuclidinone and (S) and (R)-l-phenethylamine [J]. Synth Commun, 1992, 22 (13): 1895-1911.
  • 7Lancelot JC, Rault S, Laduree D, et al. Pyrido[3,2- e]pyrrolo[1,2-a]pyrazines [J]. Chem Pharm Bull, 1985, 33 (7) : 2798-2802.
  • 8Clark RD, Miller AB, Berger J, et al. 2- (Quinuclidin-3- yl)pyrido [4,3-b] indol-l-ones and isoquinolin-l-ones potent conformationally restricted 5-HT3 receptor antagonists [J]. J Med Chem, 1993, 36 (18) : 2645-2657.
  • 9Kowalczyk BA, Dvorak CA. Total synthesis of the 5-HT3 receptor antagonist palonosetron [J]. Synthesis, 1996, 7: 816-818.
  • 10Robinson J, Rohloff JC, Kowalczyk BA. Process for preparing 2- (1 -azabicyclo [2.2.2] oct-3-yl) -2,4,5,6- tetrahydro-lH-benz[de]isoquinolin-l-one: US, 5510486 [P]. 1996-04-23. (CA 1996, 125: 58344)

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部